At the upcoming European Molecular Imaging Meeting Bruker will host a free workshop focused on the development, testing and bringing to market strategies of contrast agents of multiple imaging disciplines, especially PET and MRI. Don’t miss this exciting opportunity to explore how preclinical imaging can significantly increase the efficiency and pace of drug discovery and development, and help create more accurate models of human diseases.
Achieving Deeper Insights With Multimodal Imaging
Preclinical Imaging is on the move
Jens Waldeck, Bruker BioSpin, Germany
Multimodal In Vivo Imaging at the Crossroads of Basic Biology, Biotechnology, and Pre-Clinical Research
Matt Leevy, University Notre Dame, IN, USA
Functional structure of the mouse brain
Dominik von Elverfeldt, Freiburg, Germany
New silicon PM-based PET Albira Si: First research results and perspectives
Jose Viña Ribes, Universitat de Valencia, Spain
Plus talks from Dominique Sanglard, University Hospital of Lausanne, Switzerland and Ludec Sefc, University of Prague, Czech Republic.
Discover for yourself how investigations across the wide expanse of preclinical applications in oncology, neurology, inflammation, cardiology, and infectious diseases benefit from the complete range of imaging modalities.
3521 AL Utrecht